These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 33129711

  • 1. ATP-citrate lyase regulates stemness and metastasis in hepatocellular carcinoma via the Wnt/β-catenin signaling pathway.
    Han Q, Chen CA, Yang W, Liang D, Lv HW, Lv GS, Zong QN, Wang HY.
    Hepatobiliary Pancreat Dis Int; 2021 Jun; 20(3):251-261. PubMed ID: 33129711
    [Abstract] [Full Text] [Related]

  • 2. ATP citrate lyase promotes the progression of hepatocellular carcinoma by activating the REGγ-proteasome pathway.
    Cai Q, Zhu H, Dai Y, Zhou Q, Zhang Q, Zhu Q.
    Mol Carcinog; 2024 Oct; 63(10):1874-1891. PubMed ID: 38888205
    [Abstract] [Full Text] [Related]

  • 3. ATP citrate lyase inhibitor triggers endoplasmic reticulum stress to induce hepatocellular carcinoma cell apoptosis via p-eIF2α/ATF4/CHOP axis.
    Zheng Y, Zhou Q, Zhao C, Li J, Yu Z, Zhu Q.
    J Cell Mol Med; 2021 Feb; 25(3):1468-1479. PubMed ID: 33393219
    [Abstract] [Full Text] [Related]

  • 4. Jiedu Recipe, a compound Chinese herbal medicine, inhibits cancer stemness in hepatocellular carcinoma via Wnt/β-catenin pathway under hypoxia.
    Guo BJ, Ruan Y, Wang YJ, Xiao CL, Zhong ZP, Cheng BB, Du J, Li B, Gu W, Yin ZF.
    J Integr Med; 2023 Sep; 21(5):474-486. PubMed ID: 37453868
    [Abstract] [Full Text] [Related]

  • 5. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y, Jiang L, Hu Y, Xiao C, Xu N, Zhou J, Zhou X.
    BMC Cancer; 2017 Feb 28; 17(1):161. PubMed ID: 28241806
    [Abstract] [Full Text] [Related]

  • 6. ONECUT2 facilitates hepatocellular carcinoma metastasis by transcriptionally upregulating FGF2 and ACLY.
    Liu D, Zhang T, Chen X, Zhang B, Wang Y, Xie M, Ji X, Sun M, Huang W, Xia L.
    Cell Death Dis; 2021 Nov 27; 12(12):1113. PubMed ID: 34839358
    [Abstract] [Full Text] [Related]

  • 7. COLEC10 inhibits the stemness of hepatocellular carcinoma by suppressing the activity of β-catenin signaling.
    Cai MN, Chen DM, Chen XR, Gu YR, Liao CH, Xiao LX, Wang JL, Lin BL, Huang YH, Lian YF.
    Cell Oncol (Dordr); 2024 Oct 27; 47(5):1897-1910. PubMed ID: 39080215
    [Abstract] [Full Text] [Related]

  • 8. P7TP3 inhibits tumor development, migration, invasion and adhesion of liver cancer through the Wnt/β-catenin signaling pathway.
    Zhao J, Wang Y, Han M, Lu H, Chen X, Liu S, Yuan X, Han K, Liang P, Cheng J.
    Cancer Sci; 2020 Mar 27; 111(3):994-1007. PubMed ID: 31746531
    [Abstract] [Full Text] [Related]

  • 9. UCHL5 promotes hepatocellular carcinoma progression by promoting glycolysis through activating Wnt/β-catenin pathway.
    Wan B, Cheng M, He T, Zhang L.
    BMC Cancer; 2024 May 21; 24(1):618. PubMed ID: 38773433
    [Abstract] [Full Text] [Related]

  • 10. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway.
    Cao F, Yin LX.
    Exp Mol Pathol; 2019 Feb 21; 106():34-43. PubMed ID: 30539797
    [Abstract] [Full Text] [Related]

  • 11. ACLY-β-catenin axis modulates hepatoblastoma cell proliferation.
    Lin Y, Fang H, Ma C, Zhou J, Ding M, Sun H, Xu Y, Shan Y, Gao H, Yang L, Gu S, Li H.
    Biochem Biophys Res Commun; 2023 Jun 30; 663():104-112. PubMed ID: 37121120
    [Abstract] [Full Text] [Related]

  • 12. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling.
    Zhao YR, Wang JL, Xu C, Li YM, Sun B, Yang LY.
    Clin Sci (Lond); 2019 Jul 31; 133(14):1645-1662. PubMed ID: 31278131
    [Abstract] [Full Text] [Related]

  • 13. KIF18B promotes hepatocellular carcinoma progression through activating Wnt/β-catenin-signaling pathway.
    Yang B, Wang S, Xie H, Wang C, Gao X, Rong Y, Liu Z, Lu Y.
    J Cell Physiol; 2020 Oct 31; 235(10):6507-6514. PubMed ID: 32052444
    [Abstract] [Full Text] [Related]

  • 14. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway.
    Li B, Cao Y, Meng G, Qian L, Xu T, Yan C, Luo O, Wang S, Wei J, Ding Y, Yu D.
    EBioMedicine; 2019 Jan 31; 39():239-254. PubMed ID: 30555042
    [Abstract] [Full Text] [Related]

  • 15. Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt/β-catenin signaling pathway activation in hepatocellular carcinoma cells.
    Fan Q, Yang L, Zhang X, Ma Y, Li Y, Dong L, Zong Z, Hua X, Su D, Li H, Liu J.
    J Exp Clin Cancer Res; 2018 Jan 19; 37(1):9. PubMed ID: 29351758
    [Abstract] [Full Text] [Related]

  • 16. Long non-coding RNA SUMO1P3 promotes hepatocellular carcinoma progression through activating Wnt/β-catenin signalling pathway by targeting miR-320a.
    Wu S, Chen S, Lin N, Yang J.
    J Cell Mol Med; 2020 Mar 19; 24(5):3108-3116. PubMed ID: 31970876
    [Abstract] [Full Text] [Related]

  • 17. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway.
    Lo RC, Leung CO, Chan KK, Ho DW, Wong CM, Lee TK, Ng IO.
    Cell Death Differ; 2018 Aug 19; 25(8):1426-1441. PubMed ID: 29445127
    [Abstract] [Full Text] [Related]

  • 18. Kindlin-2 promotes hepatocellular carcinoma invasion and metastasis by increasing Wnt/β-catenin signaling.
    Lin J, Lin W, Ye Y, Wang L, Chen X, Zang S, Huang A.
    J Exp Clin Cancer Res; 2017 Sep 29; 36(1):134. PubMed ID: 28969700
    [Abstract] [Full Text] [Related]

  • 19. USP25 promotes hepatocellular carcinoma progression by interacting with TRIM21 via the Wnt/β-catenin signaling pathway.
    Liu Y, Ma J, Lu S, He P, Dong W.
    Chin Med J (Engl); 2023 Sep 20; 136(18):2229-2242. PubMed ID: 37439386
    [Abstract] [Full Text] [Related]

  • 20. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
    Sun J, Liu L, Zou H, Yu W.
    Yonsei Med J; 2019 Oct 20; 60(10):905-913. PubMed ID: 31538425
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.